Search Results - Ludwig Kappos

Refine Results
  1. 1
    Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

    Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis by Ludwig Kappos

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions

    Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions by Matthias Mehling, Ludwig Kappos, Tobias Derfuß

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Black holes in multiple sclerosis: definition, evolution, and clinical correlations

    Black holes in multiple sclerosis: definition, evolution, and clinical correlations by Mohammad Ali Sahraian, Ernst W. Radue, Sven Haller, Ludwig Kappos

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

    Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results by Jeffrey A. Cohen, Nadia Tenenbaum, Alit Bhatt, Ying Zhang, Ludwig Kappos

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review)

    Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review) by DS Goodin, Bruce A. Cohen, Paul O’Connor, Ludwig Kappos, J. Clarke Stevens

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum

    Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum by Yvonne Naegelin, Hayley Dingsdale, Katharina Säuberli, Sabine Schädelin, Ludwig Kappos, Yves‐Alain Barde

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective

    Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective by Tim Woelfle, Lucie Bourguignon, Johannes Lorscheider, Ludwig Kappos, Yvonne Naegelin, Catherine R. Jutzeler

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

    Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. by David H. Miller, Frederik Barkhof, I. Berry, Ludwig Kappos, Giuseppe Scotti, Alan J. Thompson

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction

    Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction by Reta Haselhorst, Ludwig Kappos, Deniz Bilecen, Klaus Scheffler, David M�ri, E. W. Rad�, Joachim Seelig

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

    Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis by Gıancarlo Comı, Douglas Jeffery, Ludwig Kappos, Xavier Montalbán, Alexey Boyко, Maria A. Rocca, Massimo Filippi

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

    Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis by Goeril Karlsson, Gordon Francis, Gideon Koren, Peter Heining, Xiaoli Zhang, Jeffrey A. Cohen, Ludwig Kappos, William Collins

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4<sup>+</sup>T Cells of Patients with Relapsing-Remitting Multiple Sclerosis

    Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4<sup>+</sup>T Cells of Patients with Relapsing-Remitting Multiple Sclerosis by Maria Meira, Claudia Sievers, Francine Hoffmann, Maria Rasenack, Jens Kühle, Tobias Derfuß, Ludwig Kappos, Raija L.P. Lindberg

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Computer assisted retraining of attentional impairments in patients with multiple sclerosis

    Computer assisted retraining of attentional impairments in patients with multiple sclerosis by Andrea M. Plohmann, Ludwig Kappos, W Ammann, A Thordai, Aymric Wittwer, S. J. Huber, Y Bellaiche, Jeannette Lechner‐Scott

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

    Clinical effects of natalizumab on multiple sclerosis appear early in treatment course by Ludwig Kappos, Paul O’Connor, Christopher H. Polman, Patrick Vermersch, Heinz Wiendl, Amy Pace, Annie Zhang, Christophe Hotermans

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

    Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results by Helmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, María Trojano, Heinz Wiendl, Ruchi Patel, A. Zhang, Christophe Hotermans, Shibeshih Belachew

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    MS quality of life, depression, and fatigue improve after mindfulness training

    MS quality of life, depression, and fatigue improve after mindfulness training by Paul Grossman, Ludwig Kappos, Henrik Gensicke, Melba Sheila D’Souza, David C. Mohr, Iris‐Katharina Penner, C Steiner

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

    Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. by A Valli, Alessandro Sette, Ludwig Kappos, Carla Oseroff, John Sidney, G Miescher, Martina Hochberger, Eliseo Albert, Luciano Adorini

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies

    Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM st... by Eva Havrdová, Gavin Giovannoni, Ralf Gold, Robert Fox, Ludwig Kappos, J. Theodore Phillips, Macaulay Okwuokenye, Jing L. Marantz

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

    Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis by Nelly Siller, Jens Kühle, Muthuraman Muthuraman, Christian Barro, Timo Uphaus, Sergiu Groppa, Ludwig Kappos, Frauke Zipp, Stefan Bittner

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE

    Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE by Ralf Gold, Douglas L. Arnold, Amit Bar‐Or, Robert J. Fox, Ludwig Kappos, Chongshu Chen, Becky Parks, Catherine Miller

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: